Cite
HARVARD Citation
Kolehmainen, S. et al. (2021). Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting. Scandinavian journal of gastroenterology. pp. 906-913. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kolehmainen, S. et al. (2021). Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting. Scandinavian journal of gastroenterology. pp. 906-913. [Online].